Cargando…
Single-cell transcriptomics identifies potential cells of origin of MYC rhabdoid tumors
Rhabdoid tumors (RT) are rare and highly aggressive pediatric neoplasms. Their epigenetically-driven intertumoral heterogeneity is well described; however, the cellular origin of RT remains an enigma. Here, we establish and characterize different genetically engineered mouse models driven under the...
Autores principales: | Graf, Monika, Interlandi, Marta, Moreno, Natalia, Holdhof, Dörthe, Göbel, Carolin, Melcher, Viktoria, Mertins, Julius, Albert, Thomas K., Kastrati, Dennis, Alfert, Amelie, Holsten, Till, de Faria, Flavia, Meisterernst, Michael, Rossig, Claudia, Warmuth-Metz, Monika, Nowak, Johannes, Meyer zu Hörste, Gerd, Mayère, Chloe, Nef, Serge, Johann, Pascal, Frühwald, Michael C., Dugas, Martin, Schüller, Ulrich, Kerl, Kornelius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941154/ https://www.ncbi.nlm.nih.gov/pubmed/35318328 http://dx.doi.org/10.1038/s41467-022-29152-4 |
Ejemplares similares
-
ATRT-13. DIFFERENT CELLS OF ORIGIN PAVE THE WAY FOR MOLECULAR HETEROGENEITY IN RHABDOID TUMORS
por: Graf, Monika, et al.
Publicado: (2020) -
Combined BRD4 and CDK9 inhibition as a new therapeutic approach in malignant rhabdoid tumors
por: Moreno, Natalia, et al.
Publicado: (2017) -
ATRT-14. MACROPHAGE-TUMOR CELL INTERACTION PROMOTES ATRT PROGRESSION AND CHEMORESISTANCE
por: Melcher, Viktoria, et al.
Publicado: (2020) -
Smarcb1 Loss Results in a Deregulation of esBAF Binding and Impacts the Expression of Neurodevelopmental Genes
por: Alfert, Amelie, et al.
Publicado: (2022) -
BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors
por: Krämer, Katja F., et al.
Publicado: (2017)